1-3 of 3
Lorenzo Tozzi, BSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RAD001, An Inhibitor of mTOR, Shows Clinical Activity in a Phase I/II Study in Patients with Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (PPV/PET MF).

Alessandro M. Vannucchi, MD, Paola Guglielmelli, MD, Elisabetta Gattoni, MD, Elisabetta Antonioli, MD, Costanza Bogani, PhD, Lorenzo Tozzi, BSc, Lisa Pieri, MD, Alberto Bosi, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Giovanni Barosi, MD
Journal: Blood
Blood (2009) 114 (22): 307.
https://doi.org/10.1182/blood.V114.22.307.307
Published: 2009
Journal Articles

The mTOR Inhibitor, RAD001, Inhibits the Growth of Cells From Patients with Myeloproliferative Neoplasms.

Alessandro M. Vannucchi, MD, Costanza Bogani, PhD, Niccolò Bartalucci, BSc, Paola Guglielmelli, MD, Lorenzo Tozzi, BSc, Elisabetta Antonioli, MD, Lisa Pieri, MD, Alberto Bosi, MD
Journal: Blood
Blood (2009) 114 (22): 2914.
https://doi.org/10.1182/blood.V114.22.2914.2914
Published: 2009
Journal Articles

Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.

Paola Guglielmelli, MD, Lorenzo Tozzi, BSc, Vanessa Ponziani, PhD, Elisa Bianchi, PhD, Ilaria Iacobucci, PhD, Betty Giusti, PhD, Luciana Rossi, PhD, Giovanni Martinelli, MD, Rossella Manfredini, MD, Alberto Bosi, MD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2009) 114 (22): 3896.
https://doi.org/10.1182/blood.V114.22.3896.3896
Published: 2009